Toews Corp Abb Vie Inc. Transaction History

Toews Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $681,309 - $788,715	5,100 New	5,100 $760,000
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $511,747 - $613,719	-3,700 Reduced 43.53%	4,800 $776,000
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $67,105 - $76,965	500 Added 6.25%	8,500 $1.14 Million
Q2 2022 Jul 19, 2022	BUY	$137.62 - $174.96 $756,910 - $962,280	5,500 Added 220.0%	8,000 $1.23 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $329,950 - $409,375	2,500 New	2,500 $405,000
Q4 2021 Jan 27, 2022	SELL	$107.43 - $135.93 $408,234 - $516,534	-3,800 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $404,320 - $458,964	3,800 New	3,800 $410,000
Q2 2021 Aug 02, 2021	SELL	$105.21 - $117.21 $936,369 - $1.04 Million	-8,900 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $910,470 - $1 Million	8,900 New	8,900 $963,000
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $893,439 - $1.21 Million	-11,100 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $953,601 - $1.12 Million	11,100 New	11,100 $972,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Toews Corp , based on Form 13F filings with the SEC.

Stay updated on Toews Corp with notifications on news.